Showing 201 - 220 results of 570 for search '"retina"', query time: 0.05s Refine Results
  1. 201

    Persistence of Retinopathy of Prematurity in an Infant with Tetralogy of Fallot by Murat Gunay, Taner Yavuz, Gokhan Celik, Gunay Uludag

    Published 2016-01-01
    “…At 6 months of postnatal age, the infant still had an avascular peripheral retina with the demarcation line in Zone II. Even though this index subject did not have any typical risk factors for ROP, TOF seems to be the probable reason for developing as well as persistence of avascular retina.…”
    Get full text
    Article
  2. 202

    The Amelioration of Detrimental Biochemical Anomalies by Supplementing B, C, and E Vitamins in Subjects with Type 2 Diabetes Mellitus May Reduce the Rate of Development of Diabetic... by Subhasish Pramanik, Kaustav Banerjee, Lakshmi Kanta Mondal

    Published 2022-01-01
    “…All these detrimental biochemical anomalies ultimately attack biological membranes and especially capillary beds of the retina, resulting in the breakdown of the inner blood-retinal barrier and the initiation of diabetic retinopathy (DR). …”
    Get full text
    Article
  3. 203

    Optic Disk Pit with Sudden Central Visual Field Scotoma by Nikol Panou, Demetrios G. Vavvas

    Published 2016-01-01
    “…OCT revealed absence of serous retinal detachment, but disclosed inner retina thinning corresponding to the area of the visual field loss. …”
    Get full text
    Article
  4. 204
  5. 205

    Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA): A Targeted Antioxidant Strategy to Counter Oxidative Stress in Retinopathy by Marco Zeppieri, Caterina Gagliano, Fabiana D’Esposito, Mutali Musa, Irene Gattazzo, Maria Sole Zanella, Federico Bernardo Rossi, Alessandro Galan, Silvia Babighian

    Published 2024-12-01
    “…This comprehensive review aims to evaluate the current literature on the role of omega-3 fatty acids, exploring their mechanisms of action and anti-inflammatory, anti-angiogenic, and neuroprotective roles in the retina. Omega-3s have been shown to inhibit abnormal blood vessel growth in the retina, which is a significant factor in proliferative diabetic retinopathy and neovascular AMD. …”
    Get full text
    Article
  6. 206

    Thioredoxin-interacting protein (TXNIP) inhibition promotes retinal ganglion cell survival and facilitates M1-like microglial transformation via the PI3K/Akt pathway in glaucoma by Junjue Chen, Huimin Zhong, Bingqiao Shen, Huan Yu, Yang Zhang, Ruiqi Han, Ping Huang, Shouyue Huang, Yisheng Zhong

    Published 2024-12-01
    “…Western blot, RT-PCR, immunofluorescence and F-VEP were used to detect neuroinflammation level, glial activation and RGCs survival in retina of wild type, TXNIP knockout and MCC950 treatment COH mice. …”
    Get full text
    Article
  7. 207

    Prospective Evaluation of Results of Surgical Treatment of Patients with Idiopathic Macular Hole by Phacovitrectomy and Combined Cataract and Vitrectomy Surgery by Kinga Tochman-Kanty, Monika Jasielska, Jerzy Mackiewicz

    Published 2024-05-01
    “…Material and methods: The study included 33 patients (33 eyes) with idiopathic macular hole treated at the Department of Retina and Vitreous Surgery in Lublin. Twenty-one eyes were surgically treated with phacovitrectomy (Group 1 MH). …”
    Get full text
    Article
  8. 208

    Teleguided photocoagulation treatments across continents with a remotely programmed laser for retinal diseases by Andrea Cusumano, Robin Ross, Benedetto Falsini, Marco Lombardo

    Published 2025-01-01
    “…Remote teleguided retinal photocoagulation appears feasible, offering a promising tool for global collaborations in retina care and potential benefits to regions with limited access to expert supervision.…”
    Get full text
    Article
  9. 209

    Cellular Signaling in Müller Glia: Progenitor Cells for Regenerative and Neuroprotective Responses in Pharmacological Models of Retinal Degeneration by Yang Liu, Chenguang Wang, Guanfang Su

    Published 2019-01-01
    “…In contrast to stem cells, as embryonic/pluripotent stem cell-derived retinal progenitor cell or mesenchymal stem cells, Müller glia provided an endogenous cellular source for regenerative therapy in the retina. Müller glia are a major component of the retina and considerable evidence suggested these cells can be induced to produce the lost neurons in several species. …”
    Get full text
    Article
  10. 210

    Hematological- and Neurological-Expressed Sequence 1 Gene Products in Progenitor Cells during Newt Retinal Development by Tatsushi Goto, Fumio Tokunaga, Osamu Hisatomi

    Published 2012-01-01
    “…In this study, we investigated the distribution of the HN1 protein, the product of the Hn1 gene, in the developing retinas. Our immunohistochemical analyses suggested that the HN1 protein was highly expressed in an immature retina, and the subcellular localization changed during this retinogenesis as observed in newt retinal regeneration. …”
    Get full text
    Article
  11. 211
  12. 212

    Evaluation of the effectiveness of combination therapy for post-occlusive retinal changes by A.G. Shchuko, S.I. Zhukova, M.V. Akulenko

    Published 2022-07-01
    “…In group 2 patients with an area of macular ischemia from 1.5 to 1.8 mm2, an average of 7.2±2.2 injections of ranibizumab were required to relieve macular edema, in 62% of cases, sectoral laser coagulation, in 15% – panretinal laser coagulation of the retina, while visual acuity improved unreliably (p>0.05). …”
    Get full text
    Article
  13. 213
  14. 214

    Systemic regulation of retinal medium-chain fatty acid oxidation repletes TCA cycle flux in oxygen-induced retinopathy by Almut Heinken, John M. Asara, Gopalan Gnanaguru, Charandeep Singh

    Published 2025-01-01
    “…Especially, induction of hyperoxia driven anaplerosis in neurovascular tissues such as the retina during early stages of development could deplete biosynthetic precursors from newly proliferating endothelial cells impeding physiological angiogenesis and leading to vasoobliteration. …”
    Get full text
    Article
  15. 215

    Retinal Damage Induced by Internal Limiting Membrane Removal by Rachel Gelman, William Stevenson, Claudia Prospero Ponce, Daniel Agarwal, John Byron Christoforidis

    Published 2015-01-01
    “…It has a fundamental role in the development, structure, and function of the retina, although it also is a pathologic component in the various vitreoretinal disorders, most notably in macular holes. …”
    Get full text
    Article
  16. 216

    Surgical and Visual Outcome for Recurrent Retinal Detachment Surgery by Constantin Pournaras, Chrysanthi Tsika, Catherine Brozou, Miltiadis K. Tsilimbaris

    Published 2014-01-01
    “…Anatomical success (attached retina) or failure (totally/partially-detached retina) was assessed biomicroscopically. …”
    Get full text
    Article
  17. 217

    Retinal and Corneal Toxicity and Pharmacokinetic Analysis of Intraocular Injection of Ganciclovir in Rabbit Eyes by Bin-jia Sun, Rong-mei Peng, Qing Lu, Jing Hong

    Published 2019-01-01
    “…Corneal edema was obvious with endothelial cytoarchitecture damaged after intracameral injection; fluid retention also existed in retina. Conclusions. GCV intravitreal injection offers effective, sustained drug concentration in the anterior chamber, and its damage to retina receded over time. …”
    Get full text
    Article
  18. 218

    The Threshold of the Severity of Diabetic Retinopathy below Which Intensive Glycemic Control Is Beneficial in Diabetic Patients: Estimation Using Data from Large Randomized Clinica... by Yuqi Liu, Juan Li, Jinfang Ma, Nanwei Tong

    Published 2020-01-01
    “…Intensive glucose therapy can protect the retina of individuals with diabetes, but it is unknown if it provides the same protection to patients with different severity of diabetic retinopathy (DR). …”
    Get full text
    Article
  19. 219

    Switching to faricimab from the current anti-VEGF therapy: evidence-based expert recommendations by Sanjay Sharma, David T Wong, Shaheer Aboobaker, David Maberley, Pradeepa Yoganathan

    Published 2025-01-01
    “…These evidence-based expert recommendations from a panel of retina specialists consolidate current evidence with clinical experience for the optimal use of faricimab in patients with nAMD or DME, with a focus on switching from an anti-VEGF agent to faricimab.…”
    Get full text
    Article
  20. 220